V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004345 | 220001757 | 1.67 | 96.6 | null | 2013-02-23 | 2013-02-28 | AML17 TRIAL | Y | N | 220025856 | AML17 TRIAL |
| 220004346 | 220010871 | 1.75 | null | Disease modification (D) | 2013-08-28 | 2013-08-28 | Cytarabine Low Dose | 2 | N | 220025857 | CYTARABINE |
| 220004347 | 220010871 | 1.63 | 71 | Palliative (P) | 2015-12-05 | 2015-12-10 | Cytarabine Low Dose | 02 | null | 220025857 | CYTARABINE |
| 220004348 | 220010871 | 1.59 | 98 | null | 2015-03-13 | 2015-03-13 | AML17 TRIAL | N | null | 220025857 | AML17 TRIAL |
| 220004349 | 220020261 | 1.79 | 62.3 | Palliative (P) | 2017-04-12 | 2017-04-25 | Trial Unspecified | Y | N | 220025862 | TRIAL |
| 220004350 | 220001758 | 1.75 | 79.8 | Curative (C) | 2014-04-09 | 2014-04-13 | AML17 TRIAL | Y | N | 220025866 | AML17 TRIAL |
| 220004351 | 220001758 | 1.86 | 81.4 | Palliative (P) | 2013-05-17 | 2013-05-17 | AML17 TRIAL | 01 | N | 220025866 | AML17 TRIAL |
| 220004352 | 220001758 | null | 75.4 | Disease modification (D) | 2016-07-07 | 2016-07-07 | Cytarabine Low Dose | N | null | 220025866 | CYTARABINE |
| 220004353 | 220001758 | 1.71 | 68 | Curative (C) | 2014-11-14 | 2014-11-14 | AML17 TRIAL | 01 | N | 220025866 | AML17 TRIAL |
| 220004354 | 220001759 | 1.48 | 64.4 | Disease modification (D) | 2014-03-12 | 2014-03-15 | Trial Unspecified | 01 | N | 220025874 | TRIAL |
| 220004355 | 220001759 | 1.77 | null | Disease modification (D) | 2015-09-11 | 2015-09-11 | Cytarabine low (10to20mg/m2) IV/SC | N | Y | 220025874 | CYTARABINE |
| 220004356 | 220001759 | 1.73 | 81.4 | Curative (C) | 2017-07-23 | 2017-07-26 | AML17 TRIAL | N | N | 220025874 | AML17 TRIAL |
| 220004357 | 220018648 | 1.63 | null | Not known (9) | 2014-11-13 | 2014-11-19 | AML17 TRIAL | Y | N | 220025885 | AML17 TRIAL |
| 220004358 | 220018648 | 1.5 | null | Disease modification (D) | 2013-09-03 | 2013-09-03 | Trial Unspecified | Y | null | 220025885 | TRIAL |
| 220004359 | 220001760 | 1.65 | 74.5 | null | 2013-10-15 | 2013-10-18 | Trial Unspecified | Y | N | 220025888 | TRIAL |
| 220004360 | 220001761 | 1.65 | 61.5 | Disease modification (D) | 2017-09-15 | 2017-09-16 | LI-1 TRIAL | 1 | N | 220025891 | TRIAL |
| 220004361 | 220001761 | null | 0 | Palliative (P) | 2016-05-08 | 2016-05-08 | Cytarabine Low Dose | N | N | 220025891 | CYTARABINE |
| 220004362 | 220001761 | null | 81.4 | Curative (C) | 2014-05-01 | 2014-05-02 | Trial Unspecified | Y | N | 220025891 | TRIAL |
| 220004363 | 220001761 | 1.7 | null | Curative (C) | null | 2014-07-10 | Cytarabine Low Dose | null | null | 220025891 | CYTARABINE |
| 220004364 | 220001762 | 1.64 | 0 | Curative (C) | 2015-07-15 | 2015-07-19 | Trial Unspecified | 1 | null | 220025908 | TRIAL |
| 220004365 | 220001762 | null | null | Disease modification (D) | 2016-02-06 | 2016-03-19 | Cytarabine Low Dose | 2 | N | 220025908 | CYTARABINE |
| 220004366 | 220001762 | 1.72 | 78 | Curative (C) | 2013-02-11 | 2013-02-11 | AML17 TRIAL | 1 | null | 220025908 | AML17 TRIAL |
| 220004367 | 220001762 | 1.56 | null | Curative (C) | null | 2017-07-11 | Trial Unspecified | Y | N | 220025908 | TRIAL |
| 220004368 | 220001762 | 1.71 | 0 | null | 2014-11-14 | 2014-11-14 | Cytarabine Low Dose | 02 | N | 220025908 | CYTARABINE |
| 220004369 | 220001762 | 1.72 | 81 | Palliative (P) | 2013-05-18 | 2013-05-18 | Cytarabine low (10to20mg/m2) IV/SC | 2 | N | 220025908 | CYTARABINE |
| 220004370 | 220001762 | 1.58 | 62.3 | null | 2017-07-12 | 2017-07-13 | Trial Unspecified | 01 | N | 220025908 | TRIAL |
| 220004371 | 220021978 | 1.75 | 76.4 | Curative (C) | 2016-05-12 | 2016-05-12 | AML17 TRIAL | 02 | N | 220025922 | AML17 TRIAL |
| 220004372 | 220022145 | 1.7 | 54.899 | Curative (C) | 2017-03-12 | 2017-03-13 | AML17 TRIAL | N | N | 220025924 | AML17 TRIAL |
| 220004373 | 220022145 | 1.53 | 81.4 | Not known (9) | 2013-12-05 | 2013-12-05 | AML17 TRIAL | Y | N | 220025924 | AML17 TRIAL |
| 220004374 | 220022145 | null | 60.3 | Curative (C) | 2016-12-14 | 2016-12-17 | LI-1 TRIAL | Y | N | 220025924 | TRIAL |
| 220004375 | 220022314 | 1.7 | null | Curative (C) | 2014-07-02 | 2014-07-02 | Cytarabine Low Dose | N | N | 220025933 | CYTARABINE |
| 220004376 | 220022314 | 1.68 | null | Palliative (P) | 2013-07-20 | 2013-07-21 | Cytarabine Low Dose | N | N | 220025933 | CYTARABINE |
| 220004377 | 220001763 | 1.7 | 70.1 | Palliative (P) | 2014-03-25 | 2014-03-25 | Cytarabine Low Dose | 02 | N | 220025936 | CYTARABINE |
| 220004378 | 220001764 | 1.69 | 68.6 | Curative (C) | 2015-05-10 | 2015-05-10 | Trial Unspecified | 01 | N | 220025937 | TRIAL |
| 220004379 | 220001764 | 1.61 | null | Palliative (P) | 2014-05-02 | 2014-05-03 | Trial Unspecified | Y | N | 220025937 | TRIAL |
| 220004380 | 220001764 | null | 80.9 | Curative (C) | 2016-02-09 | 2016-02-11 | Trial Unspecified | 01 | N | 220025937 | TRIAL |
| 220004381 | 220001764 | 1.67 | 82.7 | Curative (C) | 2013-01-24 | 2013-01-24 | AML17 TRIAL | 1 | N | 220025937 | AML17 TRIAL |
| 220004382 | 220001765 | 1.6 | 56.3 | Curative (C) | 2015-04-29 | 2015-05-01 | AML17 TRIAL | Y | N | 220025945 | AML17 TRIAL |
| 220004383 | 220010877 | 0 | null | Curative (C) | 2013-04-04 | 2013-04-04 | AML17 TRIAL | 01 | N | 220025946 | AML17 TRIAL |
| 220004384 | 220010877 | null | null | Disease modification (D) | 2017-03-04 | 2017-03-04 | Cytarabine Low Dose | 02 | N | 220025946 | CYTARABINE |
| 220004385 | 220010877 | 1.67 | 68 | Palliative (P) | 2017-10-21 | 2017-10-21 | CYTARABINE | 2 | null | 220025946 | CYTARABINE |
| 220004386 | 220001766 | 1.52 | 65 | null | 2016-07-24 | 2016-08-05 | AML17 TRIAL | N | N | 220025950 | AML17 TRIAL |
| 220004387 | 220001766 | 1.73 | 76.7 | Curative (C) | 2015-05-24 | 2015-05-24 | Trial Unspecified | Y | N | 220025950 | TRIAL |
| 220004388 | 220001766 | 1.6 | 0 | Curative (C) | 2015-12-22 | 2015-12-22 | AML17 TRIAL | N | N | 220025950 | AML17 TRIAL |
| 220004389 | 220018653 | 1.7 | 92.4 | Not known (9) | null | 2013-11-09 | AML17 TRIAL | Y | null | 220025956 | AML17 TRIAL |
| 220004390 | 220001767 | 1.89 | 89.25 | Disease modification (D) | 2013-04-01 | 2013-04-01 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220025957 | CYTARABINE |
| 220004391 | 220010879 | 1.74 | null | Curative (C) | null | 2017-06-03 | AML17 TRIAL | null | null | 220025959 | AML17 TRIAL |
| 220004392 | 220001768 | 1.86 | null | Curative (C) | 2014-01-21 | 2014-01-22 | Trial Unspecified | Y | null | 220025960 | TRIAL |
| 220004393 | 220010880 | null | 82 | Curative (C) | 2017-08-15 | 2017-09-01 | Trial Unspecified | N | N | 220025962 | TRIAL |
| 220004394 | 220010880 | null | 89 | Palliative (P) | null | 2017-09-30 | Trial Unspecified | N | N | 220025962 | TRIAL |